Antiosteoporotic activity of Er-Xian Decoction, a traditional Chinese herbal formula, in ovariectomized rats

被引:73
作者
Nian, Hua
Qin, Lu-Ping
Zhang, Qiao-Yan
Zheng, Han-Chen
Yu, Yuan
Huang, Bao-Kang
机构
[1] Second Mil Med Univ, Sch Pharm, Dept Pharmacognosy, Shanghai 200433, Peoples R China
[2] Second Mil Med Univ, Sch Pharm, Dept Pharmaceut, Shanghai 200433, Peoples R China
基金
中国国家自然科学基金;
关键词
Er-Xian decoction (EXD); amiosteoporotic; ovariectomy; bone mineral density; mechanical strength; histomorphometry;
D O I
10.1016/j.jep.2006.04.020
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
The antiosteoporotic effect of a herbal formula, Er-Xian Decoction (EXD), in ovariectomized (OVX) rats model of osteoporosis was investigated. The rats were divided into Sham and OVX groups. The OVX rats were further sub-divided into four groups administered orally with water, nylestriol (1 mg/kg, weekly) or EXD (300, 600 mg/kg, daily) for 12 weeks. In OVX rats, the increases of body weight, serum BGP and ALP were significantly decreased by EXD treatment. In OVX rats, atrophy of uterus and descent of BMD were suppressed by treatment with EXD and nylestriol. In addition, EXD completely corrected the decreased concentration of calcium, phosphorus, and estradiol in serum observed in OVX rats. EXD also significantly increased biomechanical strength comparable to the Sham group. This was also confirmed by histological results that showed its protective action. The findings assessed on the basis of biochemical, bone mineral density, biomechanical, and histopathological parameters strongly suggested that EXD had a definite antiosteoporotic effect, which is similar to estrogen. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 31 条
[1]
Postmenopausal osteoporosis - Its clinical features [J].
Albright, F ;
Smith, PH ;
Richardson, AM .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1941, 116 :2465-2474
[2]
Immunostimulatory effect of methanol extract of Curculigo orchioides on immunosuppressed mice [J].
Bafna, AR ;
Mishra, SH .
JOURNAL OF ETHNOPHARMACOLOGY, 2006, 104 (1-2) :1-4
[3]
Bahram H.A., 1996, J NUTR, V126, P161
[4]
GROWTH-FACTORS AND THE REGULATION OF BONE REMODELING [J].
CANALIS, E ;
MCCARTHY, T ;
CENTRELLA, M .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (02) :277-281
[5]
CUMMINGS SR, 1990, CLIN ORTHOP RELAT R, P163
[6]
BONE STRENGTH - THE BOTTOM LINE [J].
EINHORN, TA .
CALCIFIED TISSUE INTERNATIONAL, 1992, 51 (05) :333-339
[7]
THE EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-1-BETA ON CELLULAR PROLIFERATION AND THE PRODUCTION OF PROSTAGLANDIN-E2, PLASMINOGEN-ACTIVATOR, OSTEOCALCIN AND ALKALINE-PHOSPHATASE BY OSTEOBLAST-LIKE CELLS DERIVED FROM HUMAN-BONE [J].
EVANS, DB ;
BUNNING, RAD ;
RUSSELL, RGG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 166 (01) :208-216
[8]
FANG ZQ, 1993, REPROD CONTRACEPTION, V13, P62
[9]
FANG ZQ, 1997, GERIATRICS HLTH CARE, V3, P12
[10]
Gao S. Q., 1999, CHINA J CHIN MAT MED, V24, P249